D-Index & Metrics Best Publications

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Neuroscience D-index 87 Citations 29,331 317 World Ranking 444 National Ranking 55
Medicine D-index 100 Citations 38,843 502 World Ranking 3687 National Ranking 357

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Gene
  • Disease

Roger A. Barker spends much of his time researching Parkinson's disease, Neuroscience, Internal medicine, Disease and Huntington's disease. His work deals with themes such as Dopaminergic, Dopamine, Psychiatry, Cognition and Dementia, which intersect with Parkinson's disease. His biological study spans a wide range of topics, including Cohort and Risk factor.

His studies in Internal medicine integrate themes in fields like Endocrinology, Oncology and Genotype. Roger A. Barker has researched Disease in several fields, including Genetics, Quality of life and Bioinformatics. His Huntington's disease research is multidisciplinary, relying on both Rating scale, Trinucleotide repeat expansion and Central nervous system disease, Degenerative disease.

His most cited work include:

  • Diagnostic Criteria for Mild Cognitive Impairment in Parkinson’s Disease: Movement Disorder Society Task Force Guidelines (1267 citations)
  • A Functional Role for Adult Hippocampal Neurogenesis in Spatial Pattern Separation (1190 citations)
  • RNA velocity of single cells (851 citations)

What are the main themes of his work throughout his whole career to date?

Roger A. Barker mainly investigates Parkinson's disease, Neuroscience, Disease, Huntington's disease and Internal medicine. He interconnects Psychiatry, Cognition and Dementia in the investigation of issues within Parkinson's disease. His studies deal with areas such as Stem cell and Transplantation as well as Neuroscience.

His work in Disease tackles topics such as Cohort which are related to areas like Pediatrics and Cohort study. His studies in Huntington's disease integrate themes in fields like Central nervous system disease and Degenerative disease. The study incorporates disciplines such as Endocrinology and Oncology in addition to Internal medicine.

He most often published in these fields:

  • Parkinson's disease (41.18%)
  • Neuroscience (33.43%)
  • Disease (33.57%)

What were the highlights of his more recent work (between 2016-2021)?

  • Parkinson's disease (41.18%)
  • Disease (33.57%)
  • Internal medicine (18.62%)

In recent papers he was focusing on the following fields of study:

His main research concerns Parkinson's disease, Disease, Internal medicine, Neuroscience and Huntington's disease. His Parkinson's disease study integrates concerns from other disciplines, such as Cognition, Dopaminergic, Dopamine and Dementia. His biological study spans a wide range of topics, including Clinical trial, Bioinformatics and Proportional hazards model.

His Internal medicine research incorporates themes from Gastroenterology and Oncology. His research in Neuroscience intersects with topics in Induced pluripotent stem cell and Alpha-synuclein. His Huntington's disease research incorporates elements of Chorea, Cancer research and Trinucleotide repeat expansion.

Between 2016 and 2021, his most popular works were:

  • RNA velocity of single cells (851 citations)
  • Targeting Huntingtin Expression in Patients with Huntington’s Disease (213 citations)
  • Excessive burden of lysosomal storage disorder gene variants in Parkinson's disease (163 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Gene
  • Disease

Roger A. Barker mostly deals with Parkinson's disease, Disease, Internal medicine, Neuroscience and Clinical trial. His Parkinson's disease study combines topics from a wide range of disciplines, such as Dementia, Dopamine, Cognition and Cohort study. His research integrates issues of Cell, Bioinformatics and Anxiety in his study of Disease.

His work deals with themes such as Magnetic resonance imaging, Oncology and Pathology, which intersect with Internal medicine. Roger A. Barker has included themes like Reprogramming and Induced pluripotent stem cell in his Neuroscience study. His study in Clinical trial is interdisciplinary in nature, drawing from both Psychological intervention, Diversity, MEDLINE and Minimal risk.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Diagnostic Criteria for Mild Cognitive Impairment in Parkinson’s Disease: Movement Disorder Society Task Force Guidelines

Irene Litvan;Jennifer G. Goldman;Alexander I. Tröster;Ben A. Schmand.
Movement Disorders (2012)

1774 Citations

A Functional Role for Adult Hippocampal Neurogenesis in Spatial Pattern Separation

C. D. Clelland;M. Choi;C. Romberg;G. D. Clemenson.
Science (2009)

1569 Citations

Evolution of cognitive dysfunction in an incident Parkinson's disease cohort

C. H. Williams-Gray;T. Foltynie;C. E. G. Brayne;T. W. Robbins.
Brain (2007)

974 Citations

Enhanced or Impaired Cognitive Function in Parkinson's Disease as a Function of Dopaminergic Medication and Task Demands

Roshan Cools;Roger A. Barker;Barbara J. Sahakian;Trevor W. Robbins.
Cerebral Cortex (2001)

952 Citations

Neuropsychological and clinical heterogeneity of cognitive impairment and dementia in patients with Parkinson's disease

Angie A Kehagia;Roger A Barker;Trevor W Robbins.
Lancet Neurology (2010)

881 Citations

The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort

Caroline H. Williams-Gray;Jonathan R. Evans;An Goris;An Goris;Thomas Foltynie.
Brain (2009)

868 Citations

RNA velocity of single cells

Gioele La Manno;Gioele La Manno;Ruslan Soldatov;Amit Zeisel;Amit Zeisel;Emelie Braun;Emelie Braun.
Nature (2018)

851 Citations

The cognitive ability of an incident cohort of Parkinson's patients in the UK. The CamPaIGN study

Thomas Foltynie;Carol E. G. Brayne;Trevor W. Robbins;Roger A. Barker.
Brain (2004)

811 Citations

Mild cognitive impairment in Parkinson disease: a multicenter pooled analysis.

D. Aarsland;K. Bronnick;C. Williams-Gray;D. Weintraub.
Neurology (2010)

807 Citations

Cognitive impairments in early Parkinson's disease are accompanied by reductions in activity in frontostriatal neural circuitry.

Simon J. G. Lewis;Anja Dove;Trevor W. Robbins;Roger A. Barker.
The Journal of Neuroscience (2003)

615 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Roger A. Barker

John R. Hodges

John R. Hodges

University of Sydney

Publications: 152

James B. Rowe

James B. Rowe

University of Cambridge

Publications: 144

Sarah J. Tabrizi

Sarah J. Tabrizi

University College London

Publications: 134

Daniela Berg

Daniela Berg

Kiel University

Publications: 133

Daniel Weintraub

Daniel Weintraub

University of Pennsylvania

Publications: 130

Dag Aarsland

Dag Aarsland

King's College London

Publications: 127

Stephen B. Dunnett

Stephen B. Dunnett

Cardiff University

Publications: 122

Jane S. Paulsen

Jane S. Paulsen

University of Wisconsin–Madison

Publications: 102

Simon J.G. Lewis

Simon J.G. Lewis

University of Sydney

Publications: 98

David J. Burn

David J. Burn

Newcastle University

Publications: 98

Andrew B. Singleton

Andrew B. Singleton

National Institutes of Health

Publications: 96

Thomas Gasser

Thomas Gasser

University of Tübingen

Publications: 92

Olivier Piguet

Olivier Piguet

University of Sydney

Publications: 84

Trevor W. Robbins

Trevor W. Robbins

University of Cambridge

Publications: 83

Anne Elizabeth Rosser

Anne Elizabeth Rosser

Cardiff University

Publications: 80

Lynn Rochester

Lynn Rochester

Newcastle University

Publications: 78

Something went wrong. Please try again later.